Pacific Biosciences of California, Inc. Stock Börse Stuttgart
Stocks
P09
US69404D1081
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.181 EUR | -2.40% |
|
-5.97% | -19.22% |
| Market Cap | 422M 371M 345M 317M 595M 40.68B 604M 4.1B 1.6B 20B 1.59B 1.55B 69.15B | P/E 2026 * |
-3.27x | P/E 2027 * | -2.88x |
|---|---|---|---|---|---|
| Enterprise Value | 422M 371M 345M 317M 595M 40.68B 604M 4.1B 1.6B 20B 1.59B 1.55B 69.15B | EV / Sales 2026 * |
2.52x | EV / Sales 2027 * | 2.17x |
| Free-Float |
91.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Pacific Biosciences of California, Inc.
| 1 week | -5.97% | ||
| Current month | -21.11% | ||
| 1 month | -5.41% | ||
| 3 months | -9.92% | ||
| 6 months | -45.51% | ||
| Current year | -19.22% |
| 1 week | 1.16 |  | 1.25 |
| 1 month | 1.16 | | 1.56 |
| 3 years | 0.8 | | 12.17 |
| 5 years | 0.8 | | 29.7 |
| 10 years | 0.8 | | 44.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Christian Henry
CEO | Chief Executive Officer | 58 | 2020-09-13 |
Jim Gibson
DFI | Director of Finance/CFO | 57 | 2025-03-30 |
Mark van Oene
COO | Chief Operating Officer | 53 | 2021-01-07 |
| Director | Title | Age | Since |
|---|---|---|---|
Bill Ericson
BRD | Director/Board Member | 67 | 2003-12-31 |
Randy Livingston
BRD | Director/Board Member | 72 | 2008-12-31 |
Marshall Mohr
BRD | Director/Board Member | 69 | 2012-01-17 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.40% | -5.97% | -14.94% | -89.78% | 422M | |
| -0.71% | +6.72% | +18.80% | -0.46% | 211B | |
| -0.52% | -6.05% | -6.80% | -25.11% | 135B | |
| +1.65% | -2.29% | -31.94% | +1.99% | 119B | |
| +1.54% | +0.50% | -58.31% | -15.57% | 65.77B | |
| -1.42% | -3.62% | +3.29% | -9.87% | 47.58B | |
| +3.03% | -0.17% | -26.91% | -33.60% | 44.44B | |
| -0.84% | +5.41% | +15.30% | +8.84% | 39.14B | |
| -2.02% | +1.54% | +23.68% | +30.76% | 36.79B | |
| -1.41% | +3.99% | +77.58% | +2.50% | 29.37B | |
| Average | -0.08% | +0.47% | -0.03% | -13.03% | 80.9B | |
| Weighted average by Cap. | -0.00% | +0.37% | -2.59% | -6.47% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 167M 147M 137M 125M 236M 16.12B 239M 1.62B 634M 7.93B 629M 615M 27.41B | 194M 171M 159M 146M 274M 18.71B 278M 1.88B 736M 9.2B 729M 714M 31.8B |
| Net income | -131M -115M -107M -98.07M -184M -12.6B -187M -1.27B -496M -6.2B -491M -481M -21.42B | -153M -134M -125M -114M -215M -14.69B -218M -1.48B -578M -7.22B -573M -560M -24.97B |
| Net Debt | - | - |
| Date | Price | Change |
|---|---|---|
| 26-07-24 | €1.181 | -2.40% |
| 26-07-23 | €1.210 | +1.04% |
| 26-07-22 | €1.198 | -2.17% |
| 26-07-21 | €1.224 | +3.68% |
| 26-07-20 | €1.181 | -6.01% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PACB Stock
- P09 Stock
Select your edition
All financial news and data tailored to specific country editions
